Dova Pharmaceuticals.

* Swedish biotech company Orphan Biovitrum bought Dova Pharmaceuticals for $868 million in cash. Dova raised $75 million in an IPO in June 2017. Shares traded for about $28 in mid-November after selling...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT